Overview

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of R89674 0.25% ophthalmic solution in healthy normal volunteers
Phase:
Phase 3
Details
Lead Sponsor:
Vistakon Pharmaceuticals
Treatments:
Ophthalmic Solutions